Literature DB >> 7962132

Bombesin stimulates the in vitro growth of a human gastric cancer cell line.

R J Bold1, P S Lowry, J Ishizuka, J F Battey, C M Townsend, J C Thompson.   

Abstract

Bombesin (BBS) and its mammalian equivalent, gastrin-releasing peptide (GRP), exhibit diverse biological functions, including that of a neurotransmitter, a regulator of gastrointestinal hormone release, and a trophic factor for various normal and neoplastic tissues. Bombesin stimulates the growth of normal cells of the stomach, pancreas, and bronchial epithelium as well as cells in breast cancer, gastrinoma, and small cell lung cancer. The purpose of this study was to determine whether BBS regulates the growth of a human gastric cancer cell line (SIIA) in vitro, and if so, to examine the mechanisms of signal-transduction that are involved. We found that BBS stimulated the growth of SIIA cells in vitro. The GRP receptor antagonists, BIM 26189 and BIM 26226, had no effect on growth of SIIA cells. Although these antagonists blocked the BBS-induced increase of [Ca2+]i, they failed to block the growth-stimulatory effect of BBS. BBS stimulated intracellular tyrosine phosphorylation of multiple proteins, with a predominant protein of apparent molecular weight of 125 kDa. Inhibition of intracellular tyrosine kinases by tyrphostin blocked the growth-stimulatory effect of BBS on SIIA cells. These results indicate that BBS exerts its trophic effect on SIIA cells through a receptor(s) linked to tyrosine kinase pathway, but not to the phospholipase C (PLC) pathway.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7962132     DOI: 10.1002/jcp.1041610315

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  7 in total

1.  Selective reconstitution of gastrin-releasing peptide receptor with G alpha q.

Authors:  M R Hellmich; J F Battey; J K Northup
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Enterotrophic effects of glucagon-like peptide 2 are enhanced by neurotensin.

Authors:  D A Litvak; B M Evers; M R Hellmich; C M Townsend
Journal:  J Gastrointest Surg       Date:  1999 Jul-Aug       Impact factor: 3.452

3.  Secretin-receptor and secretin-receptor-variant expression in gastrinomas: correlation with clinical and tumoral features and secretin and calcium provocative test results.

Authors:  Scott H Long; Marc J Berna; Michelle Thill; Andrea Pace; Tapas K Pradhan; K Martin Hoffmann; Jose Serrano; Robert T Jensen
Journal:  J Clin Endocrinol Metab       Date:  2007-08-21       Impact factor: 5.958

4.  Gastrin-releasing peptide receptor (GRPr) promotes EMT, growth, and invasion in canine prostate cancer.

Authors:  Said M Elshafae; Bardes B Hassan; Wachiraphan Supsavhad; Wessel P Dirksen; Rachael Y Camiener; Haiming Ding; Michael F Tweedle; Thomas J Rosol
Journal:  Prostate       Date:  2016-03-04       Impact factor: 4.104

Review 5.  Progress toward hormonal therapy of gastrointestinal cancer.

Authors:  R J Bold; J Ishizuka; C M Townsend
Journal:  Ann Surg       Date:  1996-01       Impact factor: 12.969

6.  Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours.

Authors:  N Scott; E Millward; E J Cartwright; S R Preston; P L Coletta
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

7.  Neuroendocrine neoplasms of gastrointestinal tract and secondary primary synchronous tumors: A systematic review of case reports. Casualty or causality?

Authors:  Rafael Parra-Medina; Paula Moreno-Lucero; Julian Jimenez-Moreno; Alejandra María Parra-Morales; Alfredo Romero-Rojas
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.